Related Experiment Video
Updated: Nov 2, 2025

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
Published on: February 2, 2024
αV β6 Integrin: An Intriguing Target for COVID-19 and Related Diseases
1Dipartimento di Scienze degli Alimenti e del Farmaco, Università di Parma, Parco Area delle Scienze 27A, 43124, Parma, Italy.
Alpha-V Beta-6 integrin shows promise for inhibiting SARS-CoV-2 entry and treating COVID-19 related fibrosis. This research explores its potential as a novel therapeutic target for the ongoing pandemic.
Area of Science:
- Virology
- Immunology
- Pulmonology
Background:
- The SARS-CoV-2 pandemic necessitates urgent development of therapeutic agents.
- COVID-19 is associated with emerging fibrotic complications in recovered patients.
- Alpha-V Beta-6 integrin is implicated in viral entry and fibrotic processes.
Purpose of the Study:
- To discuss the potential role of Alpha-V Beta-6 integrin in combating SARS-CoV-2.
- To explore Alpha-V Beta-6 integrin as a target for COVID-19 treatment and diagnosis.
- To highlight the significance of this integrin in developing new pharmacological tools.
Main Methods:
- Review of recent scientific literature and evidence.
- Analysis of the involvement of Alpha-V Beta-6 integrin in SARS-CoV-2 infection.
- Discussion of potential therapeutic and diagnostic applications.
Main Results:
- Alpha-V Beta-6 integrin may serve as a target for inhibiting SARS-CoV-2 viral entry.
- This integrin is potentially crucial for diagnosing and treating COVID-19-related fibrosis.
- Evidence suggests its underestimated role in the context of the pandemic.
Conclusions:
- Alpha-V Beta-6 integrin presents a promising target for novel antiviral therapies.
- Targeting this integrin could address both viral infection and post-COVID-19 fibrotic sequelae.
- Further research into Alpha-V Beta-6 integrin is warranted for developing effective COVID-19 treatments.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved...

